Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_assertion type Assertion NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_head.
- NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_assertion description "[While observed no correlation between ephrin ligand expression and clinical outcome in microarray datasets, ephrin-A1 and EphA2 protein co-expression was significantly associated with recurrence in Stage I prognostic breast cancer TMAs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_provenance.
- NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_assertion evidence source_evidence_literature NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_provenance.
- NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_assertion SIO_000772 21935409 NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_provenance.
- NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_assertion wasDerivedFrom befree-20150227 NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_provenance.
- NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_assertion wasGeneratedBy ECO_0000203 NP371769.RAlgRwq9hLF4QgSWAOgtdlMOrSdb9uraZpS6-r10iMlpM130_provenance.